Center for Scientific Review; Notice of Closed Meetings, 47754-47755 [2017-22139]
Download as PDF
<![CDATA[
47754
Federal Register / Vol. 82, No. 197 / Friday, October 13, 2017 / Notices
polyunsaturated fatty acid accumulates
in the brain during development, and
has been implicated in learning and
memory development. DEA, a
metabolite derived from DHA, also has
been shown to accelerate neuronal
growth and development. In vitro
studies in which neural progenitor cells
were treated with DEA derivatives
showed an increase in the number of
somatic neurons produced after
differentiation.
Potential Commercial Applications
• Neurogenesis,
• Neurite growth,
• Synaptogenesis,
• Therapeutics for traumatic brain
injury, spinal cord injury, peripheral
nerve injury, stroke, multiple sclerosis,
autism, Alzheimer’s disease,
Huntington’s disease, Parkinson’s
disease, and amyotrophic lateral
sclerosis.
Inventors: Erika Englund (NCATS),
Juan Marugan (NCATS), Samarjit
Patnaik (NCATS), Hee-Yong Kim
(NIAAA).
Intellectual Property: HHS Reference
No. E–070–2012/0, U.S. Provisional
Patent Application 61/624,741 filed
April 16, 2012 (expired), International
Patent Application PCT/US2013/032333
filed March 15, 2013 (expired), U.S.
Patent 9,422,308; German Patent
602013016154.2, French Patent
2847178, and UK Patent 2847178.
Licensing Contact: Michael
Shmilovich, Esq, CLP; 301–435–5019;
shmilovm@nih.gov.
Dated: October 5, 2017.
Michael Shmilovich,
Senior Licensing and Patenting Manager,
National Heart, Lung, and Blood Institute,
Office of Technology Transfer and
Development .
[FR Doc. 2017–22146 Filed 10–12–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
VerDate Sep<11>2014
19:23 Oct 12, 2017
Jkt 244001
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Immune
System Plasticity in Dental, Oral, and
Craniofacial Diseases.
Date: November 1, 2017.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Yi-Hsin Liu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7814, Bethesda, MD 20892, 301–435–
1781, liuyh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–17–
263: Innovation for HIV Vaccine Discovery.
Date: November 3, 2017.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Barna Dey, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184,
Bethesda, MD 20892, 301–451–2796, bdey@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Epidemiology, Ethical and
Population Sciences.
Date: November 3, 2017.
Time: 2:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Gniesha Yvonne
Dinwiddie, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3137, Bethesda, MD 20892,
dinwiddiegy@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Systems Science and Health in the
Behavioral and Social Science.
Date: November 7, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Ping Wu, Ph.D., Scientific
Review Officer, HDM IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3166,
Bethesda, MD 20892, 301–451–8428, wup4@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
Improving Smoking Cessation in
Socioeconomically Disadvantaged
Populations via Scalable Interventions.
Date: November 7, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Kristen Prentice, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3112,
MSC 7808, Bethesda, MD 20892, 301–496–
0726, prenticekj@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Digestive Sciences.
Date: November 8–9, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Martha Garcia, Ph.D.,
Scientific Reviewer Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2186,
MSC 7818, Bethesda, MD 20892, 301–435–
1243, garciamc@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Computational, Modeling, and
Biodata Management.
Date: November 8, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Allen Richon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7892, Bethesda, MD 20892, 301–379–
9351, allen.richon@nih.hhs.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Pathophysiology of
Neurodevelopmental Disorders.
Date: November 8, 2017.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Boris P Sokolov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217A,
MSC 7846, Bethesda, MD 20892, 301–408–
9115, bsokolov@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–17–
171: Cancer Tissue Engineering Collaborative
Research.
Date: November 8, 2017.
Time: 12:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
E:\FR\FM\13OCN1.SGM
13OCN1
Federal Register / Vol. 82, No. 197 / Friday, October 13, 2017 / Notices
Contact Person: Angela Y Ng, Ph.D., MBA,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6200,
MSC 7804, Bethesda, MD 20892, 301–435–
1715, nga@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Pregnancy,
Placentation, and Neonatology.
Date: November 9, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Gary Hunnicutt, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6164,
MSC 7892, Bethesda, MD 20892, 301–435–
0229, gary.hunnicutt@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 6, 2017.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–22139 Filed 10–12–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
patent applications listed below may be
obtained by emailing the indicated
licensing contact at the National Heart,
Lung, and Blood, Office of Technology
Transfer and Development Office of
Technology Transfer, 31 Center Drive
Room 4A29, MSC2479, Bethesda, MD
20892–2479; telephone: 301–402–5579.
A signed Confidential Disclosure
Agreement may be required to receive
copies of the patent applications.
SUPPLEMENTARY INFORMATION: This
notice is in accordance with 35 U.S.C.
209 and 37 CFR part 404 to achieve
commercialization of results of
federally-funded research and
development. Foreign patent
asabaliauskas on DSKBBXCHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:05 Oct 12, 2017
Jkt 244001
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing. A description of the
technology follows.
Small Interfering RNA Inhibition of
Cannabanoid-1 Receptor (CB1R) for
Treating Type 2 Diabetes
Description of Technology: The
invention pertains to the use of glucan
encapsulated non-immunostimulatory
small interfering RNAs (siRNAs) to treat
type-2 diabetes. Endocannabinoids (EC)
are lipid signaling molecules that act on
the same cannabinoid receptors that
recognize and mediate the effects of
endo- and phytocannabanoids. EC
receptor CB1R activation is implicated
in the development of obesity and its
metabolic consequences, including
insulin resistance and type 2 diabetes.
Beta-cell loss has been demonstrated in
a Zucker diabetic fatty (ZDF) rat model
of type-2 diabetes through CB1Rmediated activation of a macrophagemediated inflammatory response.
Conversely, rats treated with a
peripheral CB1R antagonist restores
normoglycemia and preserves beta-cell
function. Similar results are seen
following selective in vivo knockdown
of macrophage CB1R by daily treatment
of ZDF rats with the instant D-glucanencapsulated CB1R Small interfering
RNA (siRNA). Knock-down of CB1R
with using glucan encapsulated siRNA
may represent a new commecializable
method of treating type-2 diabetes or
preventing the progression of insulin
resistance to overt diabetes.
Potential Commercial Applications:
Treatment of obesity, insulin resistance,
and diabetes.
Development Stage: In vivo data
available.
Inventors: George Kunos, Tony
Jourdan (NIAAA), Michael Czech,
Myriam Aouadi.
Intellectual Property: HHS Reference
No. E–103–2013/0, U.S. Provisional
Patent Application 61/839,239 filed
June 25, 2013, International Patent
Application PCT/US2014/043924 filed
June 24, 2014, European Patent
Application 14818342.9 filed June 24,
2014 and U.S. Patent Application 14/
900,951 filed June 24, 2014.
Licensing Contact: Michael
Shmilovich, Esq, CLP; 301–435–5019;
shmilovm@nih.gov.
Dated: October 5, 2017.
Michael Shmilovich,
Senior Licensing and Patenting Manager,
National Heart, Lung, and Blood Institute,
Office of Technology Transfer and
Development.
[FR Doc. 2017–22147 Filed 10–12–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
47755
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Neurological Sciences
Training Initial Review Group; NST–2
Subcommittee.
Date: October 23, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Crystal City, 2399 Jefferson
Davis Highway, Arlington, VA 22202.
Contact Person: Elizabeth Webber, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–1917, Webbere@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; R13 Review.
Date: October 26, 2017.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Ernie Lyons, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–4056, lyonse@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; F32 and K22 Review.
Date: November 2–3, 2017.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\13OCN1.SGM
13OCN1
]]>Agencies
[Federal Register Volume 82, Number 197 (Friday, October 13, 2017)]
[Notices]
[Pages 47754-47755]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-22139]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Immune System Plasticity in Dental, Oral, and Craniofacial
Diseases.
Date: November 1, 2017.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yi-Hsin Liu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4214, MSC 7814, Bethesda, MD 20892, 301-435-
1781, liuyh@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-17-263: Innovation for HIV Vaccine Discovery.
Date: November 3, 2017.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Barna Dey, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3184, Bethesda, MD 20892, 301-451-2796,
bdey@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Epidemiology, Ethical and Population
Sciences.
Date: November 3, 2017.
Time: 2:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Gniesha Yvonne Dinwiddie, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3137, Bethesda, MD 20892,
dinwiddiegy@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Systems Science and Health in the Behavioral and
Social Science.
Date: November 7, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Ping Wu, Ph.D., Scientific Review Officer, HDM
IRG, Center for Scientific Review, National Institutes of Health,
6701 Rockledge Drive, Room 3166, Bethesda, MD 20892, 301-451-8428,
wup4@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Improving Smoking Cessation in Socioeconomically
Disadvantaged Populations via Scalable Interventions.
Date: November 7, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Kristen Prentice, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3112, MSC 7808, Bethesda, MD
20892, 301-496-0726, prenticekj@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Digestive Sciences.
Date: November 8-9, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Martha Garcia, Ph.D., Scientific Reviewer
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2186, MSC 7818, Bethesda, MD
20892, 301-435-1243, garciamc@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Computational, Modeling, and Biodata
Management.
Date: November 8, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Allen Richon, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6184, MSC 7892, Bethesda, MD 20892, 301-379-
9351, allen.richon@nih.hhs.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Pathophysiology of Neurodevelopmental
Disorders.
Date: November 8, 2017.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Boris P Sokolov, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217A, MSC 7846, Bethesda, MD
20892, 301-408-9115, bsokolov@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-17-171: Cancer Tissue Engineering Collaborative Research.
Date: November 8, 2017.
Time: 12:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
[[Page 47755]]
Contact Person: Angela Y Ng, Ph.D., MBA, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6200, MSC 7804, Bethesda, MD
20892, 301-435-1715, nga@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Pregnancy, Placentation, and Neonatology.
Date: November 9, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Gary Hunnicutt, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6164, MSC 7892, Bethesda, MD
20892, 301-435-0229, gary.hunnicutt@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 6, 2017.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-22139 Filed 10-12-17; 8:45 am]
BILLING CODE 4140-01-P
